Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Voyage Biomedical's core mission is to innovate brain cooling technology to combat stroke damage. Their primary product focuses on using cooling techniques to minimize brain damage during strokes. The company targets the medical technology market, specifically aiming to improve outcomes for stroke patients.
Voyage Biomedical has achieved significant milestones, including its acquisition by Penumbra, a publicly traded company on the NYSE. This acquisition underscores the impact and potential of their technology in the medical field.
Operating Status
Acquired
Ownership Type(s)
Venture Capital
Technology
HealthTech, Biotech
Tags
Hardware
Revenue Type(s)
United States
Customer Type(s)
Consumers
When was Voyage Biomedical founded?
Voyage Biomedical was founded in 2018.
Where is Voyage Biomedical's headquarters located?
Voyage Biomedical's headquarters is located in San Francisco, CA, US.
When was Voyage Biomedical's last funding round?
Voyage Biomedical's most recent funding round was for $150k (USD) in April 2019.
How many employees does Voyage Biomedical have?
Voyage Biomedical has 2 employees as of Feb 4, 2024.
How much has Voyage Biomedical raised to-date?
As of July 05, 2023, Voyage Biomedical has raised a total of $150k (USD) since Apr 20, 2019.
Add Comparison
Total Raised to Date
$150k
USD
Last Update Apr 20, 2019
Last Deal Details
$150k
USD
Apr 20, 2019
Pre Seed
Current Employees
2
(over the past year)
Last updated: Feb 4, 2024
Employee Growth Trend
High
Medium
Low
Hover over data points to see confidence level and exact employee count
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts